The prevalence of arteriosclerosis obliterans (ASO) and critical limb ischemia (CLI) is currently increasing, and arterial reconstruction is often attempted to salvage the limb. Some patients cannot undergo attempted revascularization because of contraindications, and they only receive conservative treatment. In this study, we investigate the comorbidities and survival rates of patients with CLI who receive conservative treatment. Thirtyfive patients with CLI due to ASO, who had not undergone revascularization surgery (C group), were enrolled. As controls, 136 patients with CLI due to ASO who did undergo revascularization (R group), mainly via bypass surgery, were enrolled. Coronary artery disease, heart failure, and respiratory dysfunction were factors indicating conservative treatment. Limb salvage rates and survival rates were not significantly different between the two groups. Patients who had survived for less than two years after surgery had a higher prevalence of chronic heart failure, cardiovascular disease, and end-stage renal disease compared to patients who had survived for more than two years. The use of statins, dual antiplatelets, aspirin, or warfarin did not influence whether a patient survived for longer than two years. 77% of patients survived for more than two years after receiving only conservative therapies. Surgical revascularization did not improve the prognosis of patients with CLI as compared with the conservative therapy. Clinicians might start with conservative treatment while considering other treatment options for patients with CLI.
A rteriosclerosis obliterans (ASO) is a major risk factor of peripheral arterial diseases (PADs). The causes of ASO are multifactorial, such as diabetes mellitus (DM), dyslipidemia, hypertension, and smoking. The number of patients with PAD is currently increasing. Patients with PAD often present with accompanying severe comorbidities, including coronary artery disease (CAD) leading to chronic heart failure (CHF), cerebrovascular disease (CVD), respiratory dysfunction, and end-stage renal disease (ESRD) requiring dialysis. Critical limb ischemia (CLI) is an end-stage condition of PAD that carries a high risk of lower limb loss. Furthermore, CLI is also strongly associated with a high risk of mortality, especially due to cardiovascular events. Mortality rates for CLI in previous reports have been as high as 20% at six months after the confirmation of the diagnosis and have exceeded 50% at five years. 1) For patients with CLI, arterial revascularization is the most imperative procedure for salvaging the ischemic limbs. The most effective way to achieve revascularization is bypass surgery. Fundamentally, autologous veins are used as alternative graft material. However, patients with CLI frequently present with accompanying comorbidities and poor systemic conditions, which make highly invasive surgeries difficult and leave limited treatment options. We perform bypass surgery on most patients to achieve revascularization because it is the gold standard for revascularization. Once patients with CLI present to our department, they are admitted shortly afterward to evaluate ischemia of the lower limbs and the systemic status of comorbidities, such as cardiac function, respiratory function, and screen for malignancies. In certain patients, bypass surgery cannot be performed because of the poor systemic status or the lack of good grafting material.
Nowadays, the use of peripheral endovascular therapies (EVTs) is widespread. In our institute, EVT has not been performed for infrainguinal lesions because bypass surgery is the gold standard and the long-term patency following EVT is poor in these patients because of the high rates of restenosis. Occasionally, EVTs are effective for infrainguinal lesions, although restenosis of the target lesions often causes a relapse of ischemic symptoms. The issue of restenosis after EVT, especially in infrainguinal lesions, needs to be resolved.
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The management of patients with CLI who do not undergo surgical or endovascular interventions is considered important because patients with CLI usually have other comorbidities, which need to be controlled properly. The purpose of this study was not only to investigate additional interventional therapies but also to investigate improved outcomes for CLI, including survival rates. The importance of conservative therapies for CLI is well known; however, the actual course and outcomes for patients who do not undergo revascularization are not as well known.
We reviewed the results of conservative treatment for CLI that did not involve surgical intervention or infrainguinal EVT.
Methods
Therapeutic strategy for CLI and patient selection: Patients with CLI who were referred to our outpatient department and admitted soon afterward for conservative treatment and further examination of lower limb ischemia and systemic organ function, with a view of future arterial reconstruction (mainly bypass surgery), were included in this study. Our treatment policy for CLI is an aggressive attempt at surgical arterial reconstruction, consisting mainly of bypass surgery with autologous vein to foot area for limb salvage, as shown in our previous paper. 2) Revascularization was attempted in all patients, including those with severe systemic dysfunction when surgery was considered feasible under local or block anesthesia.
2) Arterial reconstruction was not indicated when major amputation was inevitable because of an extended infection or necrosis above the heel. Arterial reconstruction was also not indicated in patients who lacked an appropriate arterial site for anastomosis, lacked a vein graft for distal bypass surgery, had a short life expectancy because of cancer or other diseases, or lacked the ability to walk because of a consciousness disorder, paralysis, or contracture. Some patients did not agree arterial reconstruction even though surgery was feasible. Prior to this study, we did not attempt infrainguinal EVTs for revascularization because of the low patency rates and high rates of restenosis for target lesions. In this study, we enrolled all patients who did not undergo any revascularization, including surgeries and EVTs, for any reason. The conservative management of CLI consisted of medications and interventions for controlling comorbidities, if needed, and foot care. Foot care rounds were performed by the team of vascular surgeons and nurses once a day during admission in our department. The data analyzed in this study were extracted from the patients' medical records by a retrospective review. Informed consent was obtained from all patients for all research using medical records, including the present study. Patient background: This study was performed according to the guidelines of the research ethics committee of the University of Tokyo. A total 184 patients with CLI due to ASO admitted to the University of Tokyo Hospital from 2005 to 2014 were analyzed in this study. CLI was defined as Fontaine classification 3 and 4. It was defined by the presence of ischemic rest pain, nonhealing ulcers, or gangrene, along with a foot skin perfusion pressure (SPP) of < 40 mmHg. SPP has previously been proven to be an objective method for assessing limb ischemia and predicting wound healing; therefore, this parameter is routinely measured in patients with CLI.
In the same period, primary amputations were performed in 13 cases. Therefore, we excluded these cases from this study and compared patients who received conservative treatment (C group) and patients who received revascularization (R group). We included cases with only minor amputations, such as toes or small parts of the foot, without revascularization in the C group. All revascularization procedures for infrainguinal lesions were bypass surgeries. All EVTs were applied only to iliac lesions, and all patients underwent bypass surgery. The C group included 35 cases and the R group included 136 cases. The mean observation period for all patients was 32 months. The median observation period was 11 months in the C group and 35 months in the R group. Patient demographics were collected, including comorbidities such as CAD, CHF, CVD, respiratory impairment, ESRD, DM, dyslipidemia, and hypertension, as well as a history of malignancy and smoking history. Statistics: The data are presented as the mean ± standard deviation unless otherwise noted. Differences between the groups were analyzed using Student's t-test, chi-square test, or Fisher's exact test. The limb salvage and survival rates were estimated according to the Kaplan-Meier method, and statistical differences were calculated with the log-rank test. Statistical significance was defined as a P-value < 0.05.
Results
Demographic characteristics are shown in Table I . The mean age and the prevalence of DM, CAD, CVD, and ESRD with dialysis did not differ significantly between groups. Smoking and CHF were significantly more prevalent in the C group than in the R group.
The reasons why revascularization was not performed in the C group are shown in Table II . The reasons were classified into systemic factors and local factors, such as unsuitability for bypass surgery, patient refusal for surgery, and wound improvement with conservative therapy. Most of the patients had multiple reasons for not undergoing surgery. In 18 (51%) patients, systemic factors rendered them unsuitable for invasive surgery under general anesthesia, including heart failure, uncontrollable sepsis, respiratory dysfunction, hyponutrition, dementia, bedridden status, and contracture of the limb. In ten (29%) cases, local factors were responsible for the unsuitability of bypass surgery, and these included no appropriate distal anastomotic site because of severe calcification and no appropriate vein graft. In 12 (34%) cases, other reasons were suggested, such as improvement with conservative treatment and patient's choice.
Survival rates and limb salvage rates were analyzed using life-table analyses. At two years, the survival rate was 77% in the C group and 78% in the R group ( Figure  A) . The limb salvage rate at two years was 89% in the C group and 92% in the R group ( Figure B) . The limb sal-CONSERVATIVE TREATMENT FOR CRITICAL LIMB ISCHEMIA vage rates and survival rates were not significantly different in the C group and the R group. However, we should mention that the average observation period in the R group was significantly longer than that in the C group (Table I) . Eleven patients (31%) in the C group survived for longer than two years (Table III and IV) . There was a significant difference in CHF, CAD, and ESRD between patients who survived for less than two years and those who survived for more than two years (54% versus 9%, 71% versus 27%, and 67% versus 18%, respectively). The use of statins, dual antiplatelets, aspirin, or warfarin was not associated with whether a patient survived for longer than two years (Table IV) .
Discussion
Patients with CLI are at risk of limb loss and usually have multiple medical problems. This is sometimes described as a social problem because of the cost of medical services and social security benefits.
3) Arterial reconstruction is the best method for limb salvage; however, some patients cannot undergo arterial reconstruction because of systemic or local problems.
The patients who received conservative treatment for CLI were roughly divided into three groups. The first group consisted of patients with a poor systemic condition that did not permit surgery, the second group consisted of patients who experienced wound improvement with intensive conservative treatment, and the third group included patients who refused surgery. Of course, there were multiple reasons in some cases. Although many reports about revascularization for patients with CLI have been published, there are still few detailed reports about conservative treatments. [4] [5] [6] [7] [8] [9] [10] [11] In this study, the systemic problems of patients who received conservative treatment were ischemic heart disease, respiratory occlusive disease, and a bedridden status. Low cardiac function and respiratory dysfunction were the main contraindications for surgery under general anesthesia. For bypass surgeries, general anesthesia was preferred because the surgery lasted a long time and required immobilization. 12) However, severe comorbidities may prevent long survival periods and increase the risk of perioperative complications. [13] [14] [15] [16] We analyzed the results of patients who did not undergo arterial reconstruction and underwent primary major amputations. Primary amputations are performed mainly because of extended necrosis or uncontrollable infections, which had been considered inevitable at admission. These patients had no other treatment option but to undergo amputation; therefore, we excluded these amputated cases from this analysis.
The average observation period in the C group was about a year. There was a statistically significant difference in the mean observation period in the C group and the R group. In previous reports, the follow-up period for conservatively treated patients with CLI was one or two Akagi, ET AL
Figure.
Life-time analysis using the Kaplan-Meier method. Survival rates (A) and limb salvage rates (B). These two analyses show no statistical difference between the two groups. Thomas, et al. reported that the median time to mortality was seven months, and the two-year survival rate was 55% in patients with CLI who underwent conservative treatment. 10) Gu, et al. reported the one-year outcomes of 30 patients with CLI who received conservative treatment, including two patients with revascularization failure.
11) Five patients (17%) died and 11 patients (37%) un-CONSERVATIVE TREATMENT FOR CRITICAL LIMB ISCHEMIA derwent above-knee or below-knee amputations. The recommended medication strategies for patients with CLI or PAD have been reported in several reports and guidelines. 3, 4, 17, 18) The importance of medical treatment and the cessation of smoking in patients with CLI have been reported. 19) Pharmaceutical therapy consists of statins, anticoagulants, and antiplatelet drugs in addition to the cessation of smoking. 20) According to the US guidelines, the optimal medical treatment for patients with CLI consists of statins, controlling hypertension, and dual antiplatelet therapy (DAPT). 21, 22) Aspirin treatment has been popular for patients with CLI for a long time. Clopidogrel has been reported to produce good results for the management of patients with PAD. 23) DAPT consists of aspirin and clopidogrel, traditional ticlopidine, or recent prasugrel hydrochloride. As DAPT is recommended for coronary EVT with drug-eluting stents, it is also applied to PAD treatment. DAPT carries a risk of bleeding diseases such as gastrointestinal tract and intracranial bleeding. 24, 25) In our study, DAPT was administered in 25% of all patients and in 50% of patients who lived for longer than two years. The management of other medical conditions is important prior to surgery and prior to other treatments for CLI. In addition, patients with CLI who adhere to guideline-recommended therapies reportedly live longer with fewer adverse effects. 26) Other drugs such as vasodilators are used and gene and cell therapies are investigated for future treatment options. 18, 27) In the C group, the systemic conditions of patients varied widely. Some patients with poor systemic conditions could not undergo arterial reconstruction or lower limb amputation. On the other hand, 30% of those patients showed wound improvement. In addition, 20% of patients in the C group lived for more than two years. Medical treatment and proper wound care can result in limb preservation and long-term survival in some patients. The importance of foot care and the limitations experienced by patients with CLI are well known.
28) The aim of foot care for patients with CLI is cure and prevention of wound progression before revascularization. To evaluate ulcers and gangrene for continuous treatment, the Wound, Ischemia, and foot Infection (WIfI) classification has been used recently as a comprehensive evaluation system for wounds. 29, 30) The WIfI classification takes into account the wound, infection, and ischemic status and evaluates the risk of major amputation. Care of the foot wound consists of cleaning the wound, checking the status of the wound, and local administration of external medicine. Wound care nurses, family or dialysis physicians, and even families of patients can play an important role in wound care.
The treatment strategy for CLI has primarily been arterial reconstruction using bypass surgery. We adopted a bypass-first policy because of sufficient evidence of its success in limb salvage.
1-3) However, we sometimes encounter systemic problems that prevent bypass surgeries under general anesthesia. Additionally, bypass surgery is invasive and usually requires good graft material. In this study, 20% of patients chose conservative therapy because good autologous veins were not available for use as graft material.
Nowadays, the use of EVT has become widespread and has become an important option for revascularization of CLI because most interventions can be performed under local anesthesia, are less invasive, and are easily accessible. 31) Some patients with CLI with cardiac failure, respiratory impairment, strong inflammation, infection, and/or necrosis are considered not suitable for bypass surgery. Thus, EVT may be considered for such patients. In many papers on EVT, the follow-up periods were one year or less. 32) Soga, et al. reported a two-year survival rate of 59% in EVT-treated patients with CLI. 33) This result is similar to that of the C group in our study. We are still awaiting long-term follow-up data of EVT. As mentioned earlier, EVT includes high rates of restenosis, which requires patients to return to the hospital to receive repeated EVTs. 34, 35) Although some patients with CLI need urgent revascularization, conservative treatments should be used before attempting EVT or bypass surgery.
For patients with CLI and a prognosis of less-thanone-year survival, conservative treatment without revascularization surgery would be one of the treatment options, depending on the patient's systemic and local conditions.
In choosing the treatment for a patient with CLI, the prognosis, severity of comorbidities, and possibility of wound healing should be considered, along with a proper assessment of the patient's systemic and local conditions. Medical treatment is indispensable. A small number of patients who received conservative treatment lived for longer than two years. In this analysis, we cannot definitively state what the important factors are for longer survival. Large registries might be needed to decide the best medical treatments for CLI. Regarding the patients' longterm prognoses, the wounds did not worsen and most were cured. A few patients who received conservative treatment and achieved long-term survival without arterial reconstruction were cared for and had the status of their feet and comorbidities controlled.
Patients with CLI who do not undergo revascularization have many medical problems, and these should be managed to achieve long-term survival.
In this study, there were some limitations. The main limitation was the short median follow-up period, although the follow-up periods in other reports were also short. The second limitation was incomplete follow-up data despite our attempts to obtain as much patient information as possible. Patients with CLI who did not undergo arterial reconstruction were easily lost to follow-up, whereas patients with CLI who underwent revascularization were followed up more easily, as they continued to receive treatment.
Conclusion
After examination of the comorbidities and survival rates of patients with CLI who did not undergo revascularization, some patients with CLI could achieve longterm survival with conservative therapies alone. We concluded that surgical revascularization did not improve the prognosis of patients with CLI as compared with the conservative therapy. Therefore, clinicians treating patients with CLI could consider conservative therapy for these patients before attempting EVTs or bypass surgery.
